Bayir Group announces $2.45 million investment via Rabobank

By Hank Schultz contact

- Last updated on GMT

Bayir Group announces $2.45 million investment via Rabobank

Related tags: Finance, Dietary supplement

Ingredient supplier Bayir Group has announced $2.45 million in funding which will be used for a manufacturing expansion primarily aimed at pharmaceutical applications.

The cash infusion is in the form of two rounds of series B funding arranged through Rabo Equity, a subsidiary of Rabobank.  According to Investopedia, “Successive rounds of financing or funding a business are consecutively termed Series A, Series B and Series C financing. The Series B round generally takes place when the company has accomplished certain milestones in developing its business.​  Bayir said an additional $1.42 million in financing is in the offing.

The Bayir Group, which consists of BeloorBayir Biotech, Bayir Extracts and Bayir, Inc., says it has grown over the course of 35 years to a $20 million business with more than 500 customers. Its newly launched US division, Bayir, Inc., will serve as the domestic manufacturing arm for the dietary supplement, functional food and beverage, and nutraceuticals industries. The company touts its ‘Bayir Gold’ program, that it says ensures the accountability and traceability of its ingredients.

Part of the new funds will be used to support operation of a fermentation facility in Pune, India, which will be geared specifically towards production of thiocolchicoside, a muscle relaxant.  Bayir says it has developed and patented an in-house fermentation method to produce this API among its wide array of premium quality ingredients. The company maintains nine manufacturing facilities worldwide with specialties including bacopa, glucosamine, chondroitin, organic extracts, and a wide range of botanicals such as garcinia and curcumin.

Related products

show more

Meriva® Curcumin Phytosome – The Life Guardian™

Meriva® Curcumin Phytosome – The Life Guardian™

Indena: botanical ingredients for the Health Food industry | 17-Jun-2020 | Technical / White Paper

Meriva® is Indena’s bioavailable curcumin – the most studied turmeric ingredient having over 30 studies with more than 2,000 individuals

Botanicals & Immunity: Trends & Research

Botanicals & Immunity: Trends & Research

Layn Natural Ingredients: Innovate With Our Botanical Extracts | 17-Jun-2020 | Research Study

Google Trends shows consumer searches of “Immunity” are up more than 700% in 2020 - and nutraceutical consumers are looking to botanicals. Find out everything...

The Best Plant Protein Comes From The Heart

The Best Plant Protein Comes From The Heart

Applied Food Sciences | 08-Jun-2020 | Technical / White Paper

Inside every hemp seed is the 'hemp heart.' This nutritional powerhouse is also the proprietary source for a new plant-based ingredient, called...

Pycnogenol® Reduces Severity of Dry Mouth

Pycnogenol® Reduces Severity of Dry Mouth

Horphag Research | 18-May-2020 | Clinical Study

Newly published research shows daily supplementation with Pycnogenol® significantly reduced mouth dryness by 66% and demonstrated 82% improvement of saliva...

Related suppliers

Follow us

Products

View more

Webinars